The Next Big Brain Cancer Drug Could Come from Marijuana


Sy Mukherjee

9:44 PM Central

Image result for marijuana

GW Pharmaceuticals (gwph, +2.63%) is already well on its way to winning the first-ever U.S. approval for a cannabis-derived therapy. But an early trial suggests that these treatments could also be an effective way to fight one of most devastating forms of brain cancers: glioblastoma multiforme.

The U.K.-based company unveiled preliminary data Tuesday from a mid-stage study on an experimental drug combining cannabidiol and THC, the “high” producing element of marijuana. Results so far show that the drug boosted brain cancer patients’ median survival rates by about six months compared to a placebo. Typically, this type of cancer ravages the brain and (on average) leaves 70% of patients dead within two years of being diagnosed.

Click here to subscribe to Brainstorm Health Daily, our brand new newsletter about health innovations.

“We believe that the signals of efficacy demonstrated in this study further reinforce the potential role of cannabinoids in the field of oncology and provide GW with the prospect of a new and distinct cannabinoid product candidate in the treatment of glioma,” GW CEO Justin Gover said in a statement.

GW is already interpreting the results as a reason to expand its foray into cancer treatment. The company’s most advanced drug candidate, Epidiolex (for treatment of severe epilepsy related to a number of rare disorders), is closest to reaching the U.S. market. But the firm has staked out more far-reaching ambitions in an environment where cannabis-based products have been increasingly accepted.

For one, Gover thinks that cannabidiol-based therapies show plenty of promise in behavioral disorders like schizophrenia, he told Fortune last year.

Marijuana’s effect on cancer still isn’t all that clear. A big recent review by American scientists suggests the drug is effective for treating pain and nausea in cancer patients but doesn’t necessarily treat (or cause) cancer. However, GW’s drug isn’t just a bowl of weed to be smoked – it contains concentrated derivatives and is undergoing the kind of clinical testing that could provide insights hampered by U.S. policy towards studying cannabis.

CONTINUE READING…

http://fortune.com/2016/09/26/gw-pharmaceuticals-marijuana-therapy/

Hemp Industries Association Sues DEA For Ignoring 9th Circuit Decision in HIA v. DEA (& Please sign this petition for Hemp)


Hemp Industries Association Sues DEA

For Ignoring 9th Circuit Decision in HIA v. DEA

In 2001, the DEA issued new rules to ban hemp foods despite the fact that Congress had exempted them in the Controlled Substances Act. The HIA, Dr. Bronner’s, Nutiva and other plaintiffs went to the 9th Circuit Court of Appeals to challenge the illogical rules and won a victory. This ruling prohibited DEA from treating legal hemp products as controlled substances and helped the burgeoning hemp foods market to take off. 

Despite this victory and the clear order from the court prohibiting DEA from enforcing the rules, DEA has continued to put out incorrect and confusing information advising the media and state officials that hemp foods are still illegal if they are intended for human consumption! 

Today the HIA filed a motion with the court to ask that DEA be found in contempt for refusing the follow the courts order. You can read the filing here.

 

Image result for kentucky hemp

Let American Farmers Grow Hemp Once Again to Create Jobs and Rebuild the Rural Economy – Sign This Petition

Created by E.S. on January 20, 2017 – Sign This Petition

Industrial hemp was once a dominant crop on the American landscape. This hardy and renewable resource was refined for various industrial applications, including paper, textiles, and cordage. Unfortunately hemp was conflated with marijuana but hemp can't be used as a drug.

Over time, the use of industrial hemp has evolved into an even greater variety of products, including health foods, body care, clothing, auto parts, construction materials, biofuels, plastic composites and more.

Farmers in Europe, Canada and China all grow hemp and over $600 million in imported hemp products were sold in the USA in 2016. Congress has 2 bipartisan bills which would bring back hemp farming and create rural jobs. We request that President Trump work with Congress to pass hemp legislation in 2017 – Sign This PetitionSign This Petition